INSIGHT 2023: Aug 31 - Sept 3 in Berlin

Conference Updates

ticket sale now open + + + Discounted train tickets in ticket shop

First speaker line-up of INSIGHT 2023

Prof. Dr. med. Gerhard Gründer
Professor of Psychiatry

Department of Molecular Neuroimaging, Central Institute of Mental Health Mannheim
Prof. Dr. David Nutt
Professor of Neuropsychopharmacology

Imperial College London, Division of Brain Sciences
Prof. Dr. Matthias Liechti
Professor of Clinical Pharmacology and Internal Medicine

University Hospital, Basel
Dr. Katrin Preller
Senior Researcher, Psychologist, and Neuroscientist

University of Zürich and Yale University
Prof. Dr. Matthew Johnson
Susan Hill Ward Professor of Psychedelics & Consciousness Research

Johns Hopkins University School of Medicine
Dr. Martha Havenith
Research group leader, Coach for Connective Breathwork

Ernst-Strüngmann Institute for Neuroscience
Dr. Chris Letheby
Lecturer in Philosophy & Postdoctoral Researcher

University of Western Australia & University of Adelaide
Prof. Dr. Harry Sumnall
Professor in Substance Use

Public Health Institute of the Liverpool John Moores University, United Kingdom
Prof. Dr. Roland Griffiths
Professor of Psychiatry and Neurosciences

Johns Hopkins School of Medicine, Center for Psychedelic and Consciousness Research
David B. Yaden, PhD
Postdoctoral Research Fellow

Johns Hopkins Medicine, Center for Psychedelic and Consciousness Research

Looking back at
INSIGHT 2021

The last edition of INSIGHT hosted over 1300 attendees in Berlin and via live stream and offered 67 talks, 8 panel discussions, 10 exploratory art experiences, and 14 pre-conference workshops. Watch the after movie and download the Conference Report to learn more.

Download Report

Get a glimpse of

INSIGHT 2023

With the feedback and experience from 2021, we will make INSIGHT 2023 even greater, for example, by adding new elements such as multilingual conference tracks, invited symposia, and policy interaction. Participatory formats will allow us to openly discuss the pressing questions of our time, such as:
How can we critically learn from the past and ongoing studies?
Which therapist trainings have evolved, and how to assess their quality?
What is needed to make the transition from scientific research to societal integration?

INSIGHT 2023 will also report results from the largest science-initiated psilocybin study so far: the German EPIsoDE trial.
We are building bridges between physicians and psychotherapists, researchers, and the psychedelic industry and closing the gap between practitioners and the academic world of psychedelic research.

Buy Tickets